Share on LinkedInShare on LinkedIn

ARTICLE · 28 JUNE 2017

Federal Circuit Patent Updates - June 2017

WilmerHale
WilmerHale
Contributor
WilmerHale

WilmerHale

WilmerHale's London office was established more than 40 years ago. With lawyers qualified in the...

View firm profile
Explore more from WilmerHale

Reyna, J. Affirming decision that claims relating to "testing for myeloperoxidase [MPO] in a bodily sample" and "treating a patient that has cardiovascular disease" are not directed to patent-eligible...

United StatesIntellectual Property

Nexlearn, LLC v. Allen Interactions, Inc. (No. 2016-2107, -2221, 6/19/17) (Moore, Schall, Hughes)

June 19, 2017 10:09 AM

Moore, J. Affirming dismissal due to lack of personal jurisdiction. .

A full version of the text is available in PDF form.

The Cleveland Clinic v. True Health Diagnostics LLC (No. 2016-1766, 6/16/17) (Lourie, Reyna, Wallach)

June 16, 2017 3:34 PM

Reyna, J. Affirming decision that claims relating to "testing for myeloperoxidase [MPO] in a bodily sample" and "treating a patient that has cardiovascular disease" are not directed to patent-eligible subject matter. The district court did not err in addressing only representative claims. "Each limitation [raised by the patentee], however, merely recites known methods of detecting MPO or MPO derivatives and applies the correlation between these biomarkers and cardiovascular health. Where, as here, the claims 'are substantially similar and linked to the same' law of nature, analyzing

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from